TreeWAS – Variant ID: rs7916697

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
J38.0 Paralysis of vocal cords and larynx	0.015	0.985	0.000
H40.1 Primary open-angle glaucoma	0.000	0.987	0.013
H40.2 Primary angle-closure glaucoma	0.000	0.987	0.013
H40 Glaucoma	0.000	0.988	0.012
H40.9 Glaucoma, unspecified	0.000	0.989	0.011
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.011	0.989	0.000
D25.0 Submucous leiomyoma of uterus	0.010	0.990	0.000
H40.3 Glaucoma secondary to eye trauma	0.000	0.990	0.010
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.010	0.990	0.000
H40.6 Glaucoma secondary to drugs	0.000	0.991	0.009
H40.8 Other glaucoma	0.000	0.991	0.009
H40.4 Glaucoma secondary to eye inflammation	0.000	0.991	0.008
H40.5 Glaucoma secondary to other eye disorders	0.000	0.992	0.008
D25.9 Leiomyoma of uterus, unspecified	0.008	0.992	0.000
T45.0 Antiallergic and antiemetic drugs	0.007	0.993	0.000
K75.9 Inflammatory liver disease, unspecified	0.000	0.994	0.006
D25 Leiomyoma of uterus	0.006	0.994	0.000
D12.4 Descending colon	0.006	0.994	0.000
K75 Other inflammatory liver diseases	0.000	0.994	0.006
K75.4 Autoimmune hepatitis	0.000	0.994	0.006
K75.8 Other specified inflammatory liver diseases	0.000	0.995	0.005
Y42.5 Other oestrogens and progestogens	0.005	0.995	0.000
H40-H42 Glaucoma	0.000	0.995	0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.005	0.995	0.000
L85.9 Epidermal thickening, unspecified	0.000	0.995	0.005
T43.2 Other and unspecified antidepressants	0.005	0.995	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.995	0.005
K75.2 Nonspecific reactive hepatitis	0.000	0.995	0.004
K75.1 Phlebitis of portal vein	0.000	0.995	0.004
N94.1 Dyspareunia	0.000	0.995	0.005
Z90.6 Acquired absence of other parts of urinary tract	0.000	0.996	0.004
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.004	0.996	0.000
N18.8 Other chronic renal failure	0.000	0.996	0.004
K74.6 Other and unspecified cirrhosis of liver	0.000	0.996	0.004
T43.5 Other and unspecified antipsychotics and neuroleptics	0.004	0.996	0.000
K75.0 Abscess of liver	0.000	0.996	0.004
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.004	0.996	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.996	0.004
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.996	0.004
H40.0 Glaucoma suspect	0.000	0.996	0.004
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
K70-K77 Diseases of liver	0.000	0.996	0.004
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.004	0.996	0.000
K74.0 Hepatic fibrosis	0.000	0.996	0.004
J38.7 Other diseases of larynx	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
H42 Glaucoma in diseases classified elsewhere	0.000	0.996	0.004
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y42.7 Androgens and anabolic congeners	0.004	0.996	0.000
T45.5 Anticoagulants	0.004	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.004	0.996	0.000
Y42.4 Oral contraceptives	0.004	0.996	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
F31 Bipolar affective disorder	0.004	0.996	0.000
J38.2 Nodules of vocal cords	0.004	0.996	0.000
M93.9 Osteochondropathy, unspecified	0.004	0.996	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.996	0.000
N18 Chronic renal failure	0.000	0.996	0.004
K70 Alcoholic liver disease	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.003	0.996	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
N18.3 Chronic kidney disease, stage 3	0.000	0.996	0.004
Y42.9 Other and unspecified hormone antagonists	0.003	0.996	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.996	0.000
T78.2 Anaphylactic shock, unspecified	0.000	0.996	0.004
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.996	0.000
K70.1 Alcoholic hepatitis	0.000	0.996	0.004
T42.4 Benzodiazepines	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.003	0.997	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.003	0.997	0.000
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
Z86.0 Personal history of other neoplasms	0.003	0.997	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.003	0.997	0.000
K73 Chronic hepatitis, not elsewhere classified	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
D25.2 Subserosal leiomyoma of uterus	0.003	0.997	0.000
T42.3 Barbiturates	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.997	0.003
K74.5 Biliary cirrhosis, unspecified	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
J38.1 Polyp of vocal cord and larynx	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
K77 Liver disorders in diseases classified elsewhere	0.000	0.997	0.003
T47.4 Other laxatives	0.003	0.997	0.000
M94.88 Other specified disorders of cartilage (Other)	0.003	0.997	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.997	0.003
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.997	0.003
N18.9 Chronic renal failure, unspecified	0.000	0.997	0.003
K74.1 Hepatic sclerosis	0.000	0.997	0.003
N18.0 End-stage renal disease	0.000	0.997	0.003
F31.7 Bipolar affective disorder, currently in remission	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.997	0.003
T36.3 Macrolides	0.003	0.997	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.003	0.997	0.000
K71 Toxic liver disease	0.000	0.997	0.003
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.000	0.997	0.003
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.003	0.997	0.000
S12.20 Fracture of other specified cervical vertebra (closed)	0.000	0.997	0.003
K72 Hepatic failure, not elsewhere classified	0.000	0.997	0.003
M94.8 Other specified disorders of cartilage	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
M93 Other osteochondropathies	0.003	0.997	0.000
K57.2 Diverticular disease of large intestine with perforation and abscess	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
F31.8 Other bipolar affective disorders	0.003	0.997	0.000
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.003	0.997	0.000
K74.3 Primary biliary cirrhosis	0.000	0.997	0.003
E78.4 Other hyperlipidaemia	0.000	0.997	0.003
J38.6 Stenosis of larynx	0.003	0.997	0.000
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.997	0.003
N18.4 Chronic kidney disease, stage 4	0.000	0.997	0.003
N18.1 Chronic kidney disease, stage 1	0.000	0.997	0.003
T36.0 Penicillins	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
K76.6 Portal hypertension	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.003	0.997	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
M94.86 Other specified disorders of cartilage (Lower leg)	0.003	0.997	0.000
K70.0 Alcoholic fatty liver	0.000	0.997	0.003
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.997	0.003
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.997	0.003
T36.4 Tetracyclines	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
N18.5 Chronic kidney disease, stage 5	0.000	0.997	0.003
L71.9 Rosacea, unspecified	0.000	0.997	0.003
Y40.0 Penicillins	0.000	0.997	0.003
T78 Adverse effects, not elsewhere classified	0.000	0.997	0.003
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.997	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
J38.4 Oedema of larynx	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.997	0.000
H60.3 Other infective otitis externa	0.000	0.997	0.003
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.997	0.002
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.002
N18.2 Chronic kidney disease, stage 2	0.000	0.997	0.003
F33 Recurrent depressive disorder	0.003	0.997	0.000
E03.8 Other specified hypothyroidism	0.000	0.997	0.003
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.997	0.002
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.003	0.997	0.000
M94 Other disorders of cartilage	0.003	0.997	0.000
K76.9 Liver disease, unspecified	0.000	0.997	0.003
T42.1 Iminostilbenes	0.002	0.997	0.000
F31.9 Bipolar affective disorder, unspecified	0.003	0.997	0.000
K70.4 Alcoholic hepatic failure	0.000	0.997	0.002
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.002	0.997	0.000
K73.9 Chronic hepatitis, unspecified	0.000	0.998	0.002
M62.80 Other specified disorders of muscle (Multiple sites)	0.002	0.998	0.000
K71.0 Toxic liver disease with cholestasis	0.000	0.998	0.002
K71.8 Toxic liver disease with other disorders of liver	0.000	0.998	0.002
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.998	0.002
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.998	0.002
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.998	0.002
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.998	0.002
K71.2 Toxic liver disease with acute hepatitis	0.000	0.998	0.002
T40.5 Cocaine	0.002	0.998	0.000
K72.1 Chronic hepatic failure	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.002	0.998	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.000	0.998	0.002
K76 Other diseases of liver	0.000	0.998	0.002
M94.84 Other specified disorders of cartilage (Hand)	0.002	0.998	0.000
M94.83 Other specified disorders of cartilage (Forearm)	0.002	0.998	0.000
M94.82 Other specified disorders of cartilage (Upper arm)	0.002	0.998	0.000
M94.80 Other specified disorders of cartilage (Multiple sites)	0.002	0.998	0.000
K72.0 Acute and subacute hepatic failure	0.000	0.998	0.002
T78.8 Other adverse effects, not elsewhere classified	0.000	0.998	0.002
M62.8 Other specified disorders of muscle	0.002	0.998	0.000
M93.8 Other specified osteochondropathies	0.002	0.998	0.000
M93.2 Osteochondritis dissecans	0.002	0.998	0.000
M93.0 Slipped upper femoral epiphysis (nontraumatic)	0.002	0.998	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.000	0.998	0.002
M93.1 Kienbock's disease of adults	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
F30-F39 Mood [affective] disorders	0.002	0.998	0.000
M91-M94 Chondropathies	0.002	0.998	0.000
F84.5 Asperger's syndrome	0.000	0.998	0.002
G50.0 Trigeminal neuralgia	0.000	0.998	0.002
G51.0 Bell's palsy	0.002	0.998	0.000
K71.9 Toxic liver disease, unspecified	0.000	0.998	0.002
L43.9 Lichen planus, unspecified	0.000	0.998	0.002
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)	0.002	0.998	0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)	0.002	0.998	0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)	0.002	0.998	0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)	0.002	0.998	0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)	0.002	0.998	0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)	0.002	0.998	0.000
J38.5 Laryngeal spasm	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.002	0.998	0.000
M94.0 Chondrocostal junction syndrome [Tietze]	0.002	0.998	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.002	0.998	0.000
H11.0 Pterygium	0.000	0.998	0.002
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
T78.3 Angioneurotic oedema	0.000	0.998	0.002
F33.9 Recurrent depressive disorder, unspecified	0.002	0.998	0.000
F33.8 Other recurrent depressive disorders	0.002	0.998	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.998	0.002
M92 Other juvenile osteochondrosis	0.002	0.998	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
M62.83 Other specified disorders of muscle (Forearm)	0.002	0.998	0.000
I42.9 Cardiomyopathy, unspecified	0.000	0.998	0.002
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)	0.002	0.998	0.000
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.002	0.998	0.000
T78.9 Adverse effect, unspecified	0.000	0.998	0.002
L85 Other epidermal thickening	0.000	0.998	0.002
C97 Malignant neoplasms of independent (primary) multiple sites	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
M94.81 Other specified disorders of cartilage (Shoulder region)	0.002	0.998	0.000
S72.30 Fracture of shaft of femur (closed)	0.000	0.998	0.002
M94.3 Chondrolysis	0.002	0.998	0.000
M94.1 Relapsing polychondritis	0.002	0.998	0.000
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
F30 Manic episode	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.998	0.002
J34.1 Cyst and mucocele of nose and nasal sinus	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.002	0.998	0.000
F30.2 Mania with psychotic symptoms	0.002	0.998	0.000
G44.2 Tension-type headache	0.002	0.998	0.000
M94.2 Chondromalacia	0.002	0.998	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.002	0.998	0.000
D25.1 Intramural leiomyoma of uterus	0.002	0.998	0.000
K72.9 Hepatic failure, unspecified	0.000	0.998	0.002
M62.87 Other specified disorders of muscle (Ankle and foot)	0.002	0.998	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.000	0.998	0.002
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.002	0.998	0.000
K70.3 Alcoholic cirrhosis of liver	0.000	0.998	0.002
K76.1 Chronic passive congestion of liver	0.000	0.998	0.002
T39.4 Antirheumatics, not elsewhere classified	0.002	0.998	0.000
T39.2 Pyrazolone derivatives	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
M92.2 Juvenile osteochondrosis of hand	0.002	0.998	0.000
N04.9 Unspecified	0.002	0.998	0.000
M92.7 Juvenile osteochondrosis of metatarsus	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
G51.8 Other disorders of facial nerve	0.002	0.998	0.000
K76.5 Hepatic veno-occlusive disease	0.000	0.998	0.002
K76.4 Peliosis hepatis	0.000	0.998	0.002
K76.2 Central haemorrhagic necrosis of liver	0.000	0.998	0.002
M94.9 Disorder of cartilage, unspecified	0.002	0.998	0.000
M62.88 Other specified disorders of muscle (Other)	0.002	0.998	0.000
M93.26 Osteochondritis dissecans knee	0.002	0.998	0.000
M93.86 Other specified osteochondropathies, lower leg	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
F39 Unspecified mood [affective] disorder	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
F38 Other mood [affective] disorders	0.002	0.998	0.000
M62.84 Other specified disorders of muscle (Hand)	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
H60.9 Otitis externa, unspecified	0.000	0.998	0.002
M06.9 Rheumatoid arthritis, unspecified	0.002	0.998	0.000
M62.5 Muscle wasting and atrophy, not elsewhere classified	0.002	0.998	0.000
M92.6 Juvenile osteochondrosis of tarsus	0.002	0.998	0.000
S12.2 Fracture of other specified cervical vertebra	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
M91 Juvenile osteochondrosis of hip and pelvis	0.002	0.998	0.000
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.002	0.998	0.000
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.002	0.998	0.000
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.002	0.998	0.000
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.002	0.998	0.000
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.002	0.998	0.000
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.002	0.998	0.000
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.002	0.998	0.000
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.002	0.998	0.000
F30.9 Manic episode, unspecified	0.002	0.998	0.000
N41.9 Inflammatory disease of prostate, unspecified	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
G51 Facial nerve disorders	0.002	0.998	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.002	0.998	0.000
G51.3 Clonic hemifacial spasm	0.002	0.998	0.000
K29.5 Chronic gastritis, unspecified	0.000	0.998	0.002
M92.5 Juvenile osteochondrosis of tibia and fibula	0.002	0.998	0.000
M92.1 Juvenile osteochondrosis of radius and ulna	0.002	0.998	0.000
M92.9 Juvenile osteochondrosis, unspecified	0.002	0.998	0.000
M92.8 Other specified juvenile osteochondrosis	0.002	0.998	0.000
M92.4 Juvenile osteochondrosis of patella	0.002	0.998	0.000
M92.3 Other juvenile osteochondrosis of upper limb	0.002	0.998	0.000
M92.0 Juvenile osteochondrosis of humerus	0.002	0.998	0.000
M62 Other disorders of muscle	0.002	0.998	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
L85.3 Xerosis cutis	0.000	0.998	0.002
L85.2 Keratosis punctata (palmaris et plantaris)	0.000	0.998	0.002
L85.0 Acquired ichthyosis	0.000	0.998	0.002
S36.00 Injury of spleen (without open wound into cavity)	0.002	0.998	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.998	0.002
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
M62.56 Muscle wasting and atrophy, not elsewhere classified (Lower leg)	0.002	0.998	0.000
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)	0.002	0.998	0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.002	0.998	0.000
M94.19 Relapsing polychondritis (Site unspecified)	0.002	0.998	0.000
M94.18 Relapsing polychondritis (Other)	0.002	0.998	0.000
M94.17 Relapsing polychondritis (Ankle and foot)	0.002	0.998	0.000
M94.16 Relapsing polychondritis (Lower leg)	0.002	0.998	0.000
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.002	0.998	0.000
M94.14 Relapsing polychondritis (Hand)	0.002	0.998	0.000
M94.13 Relapsing polychondritis (Forearm)	0.002	0.998	0.000
M94.12 Relapsing polychondritis (Upper arm)	0.002	0.998	0.000
M94.11 Relapsing polychondritis (Shoulder region)	0.002	0.998	0.000
M94.10 Relapsing polychondritis (Multiple sites)	0.002	0.998	0.000
M94.39 Chondrolysis (Site unspecified)	0.002	0.998	0.000
M94.38 Chondrolysis (Other)	0.002	0.998	0.000
M94.37 Chondrolysis (Ankle and foot)	0.002	0.998	0.000
M94.36 Chondrolysis (Lower leg)	0.002	0.998	0.000
M94.35 Chondrolysis (Pelvic region and thigh)	0.002	0.998	0.000
M94.34 Chondrolysis (Hand)	0.002	0.998	0.000
M94.33 Chondrolysis (Forearm)	0.002	0.998	0.000
M94.32 Chondrolysis (Upper arm)	0.002	0.998	0.000
M94.31 Chondrolysis (Shoulder region)	0.002	0.998	0.000
M94.30 Chondrolysis (Multiple sites)	0.002	0.998	0.000
S02.30 Fracture of orbital floor (closed)	0.000	0.998	0.002
E04.1 Non-toxic single thyroid nodule	0.002	0.998	0.000
F30.8 Other manic episodes	0.002	0.998	0.000
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.998	0.002
K76.3 Infarction of liver	0.000	0.998	0.002
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
H60 Otitis externa	0.000	0.998	0.002
M62.55 Muscle wasting and atrophy, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
G51.9 Disorder of facial nerve, unspecified	0.002	0.998	0.000
G62.8 Other specified polyneuropathies	0.002	0.998	0.000
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified	0.002	0.998	0.000
W25.9 Unspecified place	0.002	0.998	0.000
N62 Hypertrophy of breast	0.000	0.998	0.002
M94.29 Chondromalacia (Site unspecified)	0.002	0.998	0.000
M94.28 Chondromalacia (Other)	0.002	0.998	0.000
M94.27 Chondromalacia (Ankle and foot)	0.002	0.998	0.000
M94.25 Chondromalacia (Pelvic region and thigh)	0.002	0.998	0.000
M94.24 Chondromalacia (Hand)	0.002	0.998	0.000
M94.23 Chondromalacia (Forearm)	0.002	0.998	0.000
M94.22 Chondromalacia (Upper arm)	0.002	0.998	0.000
M94.21 Chondromalacia (Shoulder region)	0.002	0.998	0.000
M94.20 Chondromalacia (Multiple sites)	0.002	0.998	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.002	0.998	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.002	0.998	0.000
M33.1 Other dermatomyositis	0.000	0.998	0.002
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
L90.0 Lichen sclerosus et atrophicus	0.000	0.998	0.002
M91.1 Juvenile osteochondrosis of head of femur [Legg-Calve-Perthes]	0.002	0.998	0.000
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.001	0.998	0.000
F30.1 Mania without psychotic symptoms	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
M62.82 Other specified disorders of muscle (Upper arm)	0.002	0.998	0.000
M94.26 Chondromalacia (Lower leg)	0.002	0.998	0.000
H66.9 Otitis media, unspecified	0.000	0.998	0.002
M62.6 Muscle strain	0.002	0.998	0.000
N04.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
F34 Persistent mood [affective] disorders	0.002	0.998	0.000
M62.58 Muscle wasting and atrophy, not elsewhere classified (Other)	0.002	0.998	0.000
M62.66 Muscle strain (Lower leg)	0.002	0.998	0.000
M94.99 Disorder of cartilage, unspecified (Site unspecified)	0.001	0.998	0.000
M94.98 Disorder of cartilage, unspecified (Other)	0.001	0.998	0.000
M94.97 Disorder of cartilage, unspecified (Ankle and foot)	0.001	0.998	0.000
M94.95 Disorder of cartilage, unspecified (Pelvic region and thigh)	0.001	0.998	0.000
M94.94 Disorder of cartilage, unspecified (Hand)	0.001	0.998	0.000
M94.93 Disorder of cartilage, unspecified (Forearm)	0.001	0.998	0.000
M94.92 Disorder of cartilage, unspecified (Upper arm)	0.001	0.998	0.000
M94.91 Disorder of cartilage, unspecified (Shoulder region)	0.001	0.998	0.000
M94.90 Disorder of cartilage, unspecified (Multiple sites)	0.001	0.998	0.000
F32.0 Mild depressive episode	0.002	0.998	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.002	0.998	0.000
F38.8 Other specified mood [affective] disorders	0.001	0.998	0.000
G50.8 Other disorders of trigeminal nerve	0.000	0.998	0.002
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.002	0.998	0.000
F38.1 Other recurrent mood [affective] disorders	0.001	0.998	0.000
G50.1 Atypical facial pain	0.000	0.998	0.002
G50 Disorders of trigeminal nerve	0.000	0.998	0.002
M62.57 Muscle wasting and atrophy, not elsewhere classified (Ankle and foot)	0.001	0.998	0.000
M62.53 Muscle wasting and atrophy, not elsewhere classified (Forearm)	0.001	0.998	0.000
M62.52 Muscle wasting and atrophy, not elsewhere classified (Upper arm)	0.001	0.998	0.000
S12.21 Fracture of other specified cervical vertebra (open)	0.000	0.998	0.001
M62.9 Disorder of muscle, unspecified	0.002	0.998	0.000
M91.9 Juvenile osteochondrosis of hip and pelvis, unspecified	0.001	0.998	0.000
M91.8 Other juvenile osteochondrosis of hip and pelvis	0.001	0.998	0.000
M91.3 Pseudocoxalgia	0.001	0.998	0.000
M91.0 Juvenile osteochondrosis of pelvis	0.001	0.998	0.000
M91.15 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Pelv	0.001	0.998	0.000
F38.0 Other single mood [affective] disorders	0.001	0.998	0.000
G51.4 Facial myokymia	0.001	0.998	0.000
G51.2 Melkersson's syndrome	0.001	0.998	0.000
G51.1 Geniculate ganglionitis	0.001	0.998	0.000
H60.5 Acute otitis externa, non-infective	0.000	0.998	0.002
M62.1 Other rupture of muscle (nontraumatic)	0.002	0.998	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
M92.10 Juvenile osteochondrosis of radius and ulna, unspecified arm	0.001	0.998	0.000
M92.51 Juvenile osteochondrosis of tibia and fibula, right leg	0.001	0.998	0.000
M92.50 Juvenile osteochondrosis of tibia and fibula, unspecified leg	0.001	0.998	0.000
M62.3 Immobility syndrome (paraplegic)	0.001	0.998	0.000
M62.2 Ischaemic infarction of muscle	0.001	0.998	0.000
M62.54 Muscle wasting and atrophy, not elsewhere classified (Hand)	0.001	0.998	0.000
M62.51 Muscle wasting and atrophy, not elsewhere classified (Shoulder region)	0.001	0.998	0.000
F30.0 Hypomania	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations